While mild cold sensitivity is a common and generally benign experience during treatment with incretin-based medications, certain symptoms warrant medical evaluation to rule out underlying conditions or complications
Skin Laxity After GLP-1 Weight Loss A realistic, non-surgical plan for tightening skin, restoring structure, and looking like yourself again There is a moment many patients describe after a successful GLP-1 weight loss journey, the scale finally reflects the work, the clothes fit, energy is back, and then the mirror delivers a surprise
We know individuals who should not take it: medullary thyroid carcinoma, a very rare endocrine disorder called MEN1
The only options listed are lipo-B12 injections and low-dose naltrexone for weight-loss support
Weight changes in the first few weeks are often minimal as your body adapts to the medication
Expert answers to our most frequently asked questions Tirzepatide is a dual GIP/GLP-1 receptor agonist that simultaneously targets two key hormones